Testing effectiveness (Phase 2)Study completedNCT00872196
What this trial is testing
A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies
Who this might be right for
Hepatitis C Virus Infection
AbbVie (prior sponsor, Abbott) 5